MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Widening the phenotype of FXTAS in females: Spasmodic dysphonia in two patients

    S. Khan, S. Williams, J. Cosgrove, J. Bamford, J. Alty (Leeds, United Kingdom)

    Objective: We present the cases of two female FXTAS patients who both developed spasmodic dysphonia (SD), also known as laryngeal dystonia. Background: Fragile-X-associated tremor/ataxia syndrome…
  • 2022 International Congress

    Increased Neutrophil to Lymphocyte Ratio Distinguish Parkinson’s Disease and Parkinson Plus Syndrome

    IH. Kwak, HI. Ma, YE. Kim (Anyang, Republic of Korea)

    Objective: To investigate the peripheral inflammatory markers distinguishing Parkinson’s disease (PD) or Parkinson plus syndrome (PPS). Background: Previous studies had suggested that peripheral inflammation may…
  • 2022 International Congress

    KMT2B episignature analysis identifies a probably hypomorphic missense variant in a family with dystonic and non-dystonic phenotypes

    S. Siegert, W. Schmidt, M. Freilinger, J. Winkelmann, N. Mirza-Schreiber, K. Oexle, M. Zech (Vienna, Austria)

    Objective: Recently, DNA methylation episignature analysis has been introduced as a tool enabling re-classification of “variants of uncertain significance“ (VUS) in lysine-specific methyltransferase 2B (KMT2B),…
  • 2022 International Congress

    Paroxysmal dystonia with phenotypic variability in ECHS1 mutation twin carriers

    G. Bonato, M. Nosadini, S. Andretta, A. Suppiej, A. Leon, S. Sartori, M. Carecchio (Padua, Italy)

    Objective: To describe 2 monozygotic twins carrying biallelic ECHS1 mutations with different clinical phenotypes Background: ECHS1 encodes for a mitochondrial short chain enoyl-CoA hydratase, a…
  • 2022 International Congress

    Social cognition in Parkinson’s disease

    G. Siripurapu, R. Rajan, D. M R, E. A, A. Gupta, V. V Y, M. Singh, R. Bhatia, M. Tripathi, A. Srivastava, M. Srivastava, B. Verma, D. Biswas (NEW DELHI, India)

    Objective: Objective: To assess deficits in social cognition among patients with Parkinson’s Disease (PD) Background: Background: Social cognition is the study of how people make…
  • 2022 International Congress

    ASYMMETRIC EARLY-ONSET PARKINSONISM DUE TO PSEN1 MUTATION

    E. Luque-Buzo, J. Pérez Sáchez, M. Gonzalez-Sanchez, A. Contreras-Chicote, S. Secades, B. Casa-Fages, F. Grandas (Madrid, Spain)

    Objective: To report a novel case of early-onset parkinsonism due to a presenilin 1 gene (PSEN1) mutation. Background: Mutations in PSEN1 gene are the most…
  • 2022 International Congress

    Paroxysmal Musician’s Dyskinesia

    J. Hislop, D. Shpiner, J. Margolesky (Miami, USA)

    Objective: To report a case of tics associated with paroxysmal kinesigenic dyskinesia in a patient with PRRT2 mutation. Background: Paroxysmal kinesigenic dyskinesia (PKD) is characterized…
  • 2022 International Congress

    A Case Series of children with Choreo-athetoid movements diagnosed with Anti-N-Methyl-D-Aspartate Receptor Encephalitis

    RP. Vasireddy, ZG. Guduru, QK. Khan (Lexington, USA)

    Objective: The intention of this case series is to raise awareness about movement disorders in Pediatric NMDA encephalitis, a potentially reversible cause of a common…
  • 2022 International Congress

    Long-term follow-up of subthalamic nucleus deep brain stimulation for Parkinson’s disease: survival and disability milestones

    R. Barbosa, L. Correia-Guedes, M. Cattoni, P. Pita-Lobo, A. Castro-Caldas, M. Fabbri, P. Bastos, H. Carvalho, L. Albuquerque, S. Reimão, A. Gonçalves Ferreira, J. Ferreirajos, M. Rosa, M. Coelho (Lisbon, Portugal)

    Objective: To characterize retrospectively the long-term survival of 109 PD patients after 8 years of STN-DBS and to identify the incidence of the milestones of…
  • 2022 International Congress

    Effect of the mGlu2/3 orthosteric agonist LY-404,039 on dyskinesia, psychosis-like behaviours, and parkinsonism in the MPTP-lesioned marmoset

    W. Kang, S. Nuara, J. Gourdon, P. Huot (Montreal, Canada)

    Objective: To assess the effect of LY-404,039 on dyskinesia, psychosis-like behaviours (PLBs) and parkinsonism in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned marmoset model of Parkinson’s disease (PD). Background:…
  • « Previous Page
  • 1
  • …
  • 624
  • 625
  • 626
  • 627
  • 628
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley